Henry Schein (NASDAQ:HSIC) Announces Earnings Results, Misses Estimates By $0.04 EPS

Henry Schein (NASDAQ:HSIC) announced its quarterly earnings data on Tuesday. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. The business had revenue of $3.19 billion for the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 EPS. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS and its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Price Performance

Henry Schein stock opened at $77.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company’s 50 day simple moving average is $74.19 and its 200-day simple moving average is $72.38. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.63.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Barrington Research boosted their price objective on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.